MUMBAI, April 15 (Reuters) - India's Alkem Laboratories
has been accused by Germany's health regulator of
fudging data on clinical trials of an antibiotic and brain
disorder drug, becoming the third Indian firm to be scrutinised
since 2014 for suspected manipulation of trial data.
Read more
No comments:
Post a Comment